Salomon & Ludwin’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Salomon & Ludwin's ELV Position: Q2 2026 in Review
Salomon & Ludwin held its Elevance Health (ELV) position steady in Q2 2026 at 229 shares worth $95.3K. The position accounts for 0.01% of the portfolio, ranked #292.
Salomon & Ludwin first reported a position in ELV in Q1 2019 and has held it in 20 quarters since. The position peaked at $1.01M in Q4 2022. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Salomon & Ludwin held 229 shares of Elevance Health worth $95.3K as of Q2 2026.
- Salomon & Ludwin left its Elevance Health share count unchanged in Q2 2026.
- Elevance Health made up 0.01% of Salomon & Ludwin's portfolio in Q2 2026, its #292 holding.
- Salomon & Ludwin first reported a position in Elevance Health in Q1 2019 and has held it in 20 quarters since.
- Salomon & Ludwin's Elevance Health position peaked at $1.01M in Q4 2022.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.